IASO BIO Announces New Development Partnership with Umoja Biopharma to Develop Ex Vivo and In Vivo Cell and Gene Therapies

/PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell...

Related Keywords

Nanjing ,Jiangsu ,China ,Shanghai ,Colorado ,United States ,Equecabtagene Autoleucel ,Umoja Biopharma ,Alan Fu ,David Fontana ,Umoja Vivovec ,Umoja Biopharma Inc ,China National Medical Products Administration ,Greater China ,Chief Financial Officer ,Chief Operating ,Chief Business Officer ,New Drug Application ,National Medical Products Administration ,Media Contact ,Iaso Bio ,